The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Xtandi, cornerstone of Pfizer's $14B Medivation buy, falls short in closely watched study

Xtandi's blockbuster Q2 growth shows why Big Pharma wants a Medivation deal

'Audacious' CVS formulary drops key meds from Sanofi, Medivation and Novartis. Yours could be next

Medivation opens its books to would-be buyers, including the formerly hostile Sanofi

British watchdogs suspend Astellas UK after investigations, audits, and a crackdown from Japanese HQ

NIH won't override patents on Astellas' pricey Xtandi to bring down prices

Most-wanted buyout target Medivation and hostile bidder Sanofi line up for board fight